in Clinical Trials
Our pipeline includes multiple biotherapeutic products in varying stages of development. Our lead biotherapeutic product, realSKIN , is currently preparing for a pivotal Phase 3 clinical trial for severe burns and has concluded preclinical work for realNERVE™ in peripheral nerve repair with a corresponding IND in process.
Learn more about the clinical program on clinicaltrials.gov
realSKIN is living skin that replaces damaged or severely burned skin to allow the patient to heal on their own; requiring fewer surgeries and faster healing.